To date, IgG in the tumor microenvironment (TME) has been considered a product of B cells and serves as an antitumor antibody. However, in this study, using a monoclonal antibody against cancer-derived IgG (Cancer-IgG), we found that cancer cells could secrete IgG into the TME. Furthermore, Cancer-IgG, which carries an abnormal sialic acid modification in the CH1 domain, directly inhibited effector T-cell proliferation and significantly promoted tumor growth by reducing CD4 + and CD8 + T-cell infiltration into tumor tissues. Mechanistic studies showed that the immunosuppressive effect of sialylated Cancer-IgG is dependent on its sialylation and binding to sialic acid-binding immunoglobulin-type lectins (Siglecs) on effector CD4 + and CD8 + T cells. Importantly, we show that several Siglecs are overexpressed on effector T cells from cancer patients, but not those from healthy donors. These findings suggest that sialylated Cancer-IgG may be a ligand for Siglecs, which may serve as potential checkpoint proteins and mediate tumor immune evasion.

No abstract

Growing evidence indicates that B cells are not the only source of immunoglobulin (Ig). To investigate this discovery further, we used μMT mice, which have a disruption of the first transmembrane exon of the μ heavy chain and do not express the membrane form of IgM. These mice lack mature B cells and thus serve as a good model to explore Ig expression by liver epithelial cells. We found that Ig heavy chains (μ, δ, γ and α) and light chains (κ and λ) were expressed in sorted liver epithelial cells of μMT mice. Surprisingly, each heavy chain class showed its respective variable region sequence characteristics in their variable region, instead of sharing the same VDJ usage, which suggests that class switching does not occur in liver epithelial cells. Moreover, the γ and α chains, but not the μ and δ chains, showed mutations in the variable region, thus indicating that different classes of Ig have different activities. Our findings support the concept that non-B cells, liver epithelial cells here, can produce different classes of Ig.

No abstract

No abstract

No abstract

No abstract

Achieving bright photon upconversion under low irradiance is of great significance and finds many stimulating applications from photovoltaics to biophotonics. However, it remains a daunting challenge to significantly intensify upconversion luminescence in small nanoparticles with a simple structure. Herein, we report the amplification of photon upconversion through engineering interfacial density of states between the core and the shell layer in sub-10 nm colloidal rare-earth ions doped fluoride nanocrystals. Through tuning of the metal cations in the shell layer of alkaline-earth-based core/shell nanoparticles, both the interfacial phonon frequency and the density of state are evidently decreased, resulting in the luminescence intensification of up to 8224 times. The generality of this upconversion enhancement strategy has been verified through expansion of this approach to alkali-based core/shell nanoparticles. The engineering of photon density of state in such core/shell nanoparticles enables dynamic display and high-level security information storage.